EMN Stock Recent News

DuPont (DD), Eastman Chemical (EMN), Avient (AVNT) and Albemarle (ALB) are likely to have benefited from cost and productivity actions amid soft demand in Q4.

EMN is expected to have benefited from cost-cutting and productivity initiatives, as well as its innovation-driven growth strategy in Q4.

Eastman Chemical has underperformed recently but shows promise with improved valuation and strategic direction, making it a conservative "Buy" for 2025. The company's strong fundamentals, diverse product portfolio, and focus on sustainability, especially in molecular recycling, position it well for future growth. Despite recent declines, Eastman's operational improvements, share buybacks, and favorable macro trends suggest significant upside potential, with expected earnings growth in the coming years.

Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Eastman Chemical (EMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

While EMN faces headwinds from weak demand and inventory de-stocking in certain markets, it benefits from cost management, pricing actions and innovation.

--(BUSINESS WIRE)--Eastman has scheduled its fourth-quarter and full-year 2024 financial results news release and SEC Form 8-K filing, teleconference and webcast.

KINGSPORT, Tenn.--(BUSINESS WIRE)--Eastman Chemical Company (NYSE:EMN) has received a score of 100 on the Human Rights Campaign Foundation's (HRCF) 2025 Corporate Equality Index.

Demand softness in specific markets and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. APD, DD and EMN are poised to navigate the industry challenges.

EMN benefits from its innovation-driven growth strategy and cost-management actions amid demand headwinds in certain markets.